Multiple sclerosis

Results: 1343



#Item
120th NSW Stem Cell Network Workshop - in collaboration with MS Research Australia Stem Cells in Multiple Sclerosis and Neurological Disease

20th NSW Stem Cell Network Workshop - in collaboration with MS Research Australia Stem Cells in Multiple Sclerosis and Neurological Disease

Add to Reading List

Source URL: www.stemcellnetwork.org.au

Language: English - Date: 2014-06-24 04:37:56
    2Insights into Type 1 Diabetes and Multiple Sclerosis Pathogenesis from Common Genetic Associations Sandeep K. Singh 1, Aziz A. Chentoufi 2, Jacob L. McCauley 3, Mehmet Tevfik Dorak 4 1Florida

    Insights into Type 1 Diabetes and Multiple Sclerosis Pathogenesis from Common Genetic Associations Sandeep K. Singh 1, Aziz A. Chentoufi 2, Jacob L. McCauley 3, Mehmet Tevfik Dorak 4 1Florida

    Add to Reading List

    Source URL: www.dorak.info

    Language: English - Date: 2016-08-17 11:57:16
      3Cigarette Smoking and Incidence of Multiple Sclerosis -- Heman et al): 69 -- Ame...Page 1 of 14 Oxford Journals • ContactUs ......

      Cigarette Smoking and Incidence of Multiple Sclerosis -- Heman et al): 69 -- Ame...Page 1 of 14 Oxford Journals • ContactUs ......

      Add to Reading List

      Source URL: thetruthaboutstuff.com

      Language: English - Date: 2017-11-15 09:36:18
        4MULTIPLE SCLEROSIS Clues to its cause URI LEIBOWITZ Department of Neurology, Hadassah University Hospital and Hebrew U+riversity-Hada.ssah Medical School,

        MULTIPLE SCLEROSIS Clues to its cause URI LEIBOWITZ Department of Neurology, Hadassah University Hospital and Hebrew U+riversity-Hada.ssah Medical School,

        Add to Reading List

        Source URL: thetruthaboutstuff.com

        Language: English - Date: 2017-11-15 09:36:19
          5CNS Vital Signs Advancing Multiple Sclerosis Care Adding Value to Your Practice by Providing Solutions for Measuring,  Monitoring and Managing Neurocognitive and Behavioral Health… www.CNSVS.com

          CNS Vital Signs Advancing Multiple Sclerosis Care Adding Value to Your Practice by Providing Solutions for Measuring,  Monitoring and Managing Neurocognitive and Behavioral Health… www.CNSVS.com

          Add to Reading List

          Source URL: www.cnsvs.com

          Language: English - Date: 2016-01-13 14:04:59
            6Microsoft Word - ASX 17_ 2 October_ ATL1102 for Multiple Sclerosis and Duchenne Muscular Dystrophy Update summary_Final

            Microsoft Word - ASX 17_ 2 October_ ATL1102 for Multiple Sclerosis and Duchenne Muscular Dystrophy Update summary_Final

            Add to Reading List

            Source URL: www.antisense.com.au

            Language: English - Date: 2017-10-02 22:11:30
              7Towards better outcomes in multiple sclerosis by addressing policy change The International MultiPlE Sclerosis Study (IMPrESS)

              Towards better outcomes in multiple sclerosis by addressing policy change The International MultiPlE Sclerosis Study (IMPrESS)

              Add to Reading List

              Source URL: www.lse.ac.uk

              Language: English - Date: 2016-04-27 10:27:33
                8Article abstract—Geographically, multiple sclerosis (MS) seems to be distributed into three cones of high, medium,. and low frequency. 0 High-frequency areas, with prevalence rates over 30 per 100,000 popula ti on, inc

                Article abstract—Geographically, multiple sclerosis (MS) seems to be distributed into three cones of high, medium,. and low frequency. 0 High-frequency areas, with prevalence rates over 30 per 100,000 popula ti on, inc

                Add to Reading List

                Source URL: thetruthaboutstuff.com

                Language: English - Date: 2017-11-15 09:36:11
                  9Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis Jenny Link1., Malin Lundkvist Ryner1*., Katharina Fink1, Christina Herma

                  Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis Jenny Link1., Malin Lundkvist Ryner1*., Katharina Fink1, Christina Herma

                  Add to Reading List

                  Source URL: www.abirisk.eu

                  Language: English - Date: 2014-05-29 07:11:27
                    1019 DecemberATL1102 for Multiple Sclerosis and Duchenne Muscular Dystrophy Update Antisense Therapeutics Limited (“ANP” or “the Company”) provides the following update on the progress of its Multiple Sclero

                    19 DecemberATL1102 for Multiple Sclerosis and Duchenne Muscular Dystrophy Update Antisense Therapeutics Limited (“ANP” or “the Company”) provides the following update on the progress of its Multiple Sclero

                    Add to Reading List

                    Source URL: www.antisense.com.au

                    Language: English - Date: 2018-02-11 19:58:19